Keywords
PI3K/AKT/mTOR pathwayProtein kinase BSignal transductionBiologyCancer researchCell growthCell biologyPharmacologyBiochemistry
Affiliated Institutions
Related Publications
Targeting PI3K/Akt signal transduction for cancer therapy
The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays a crucial role in various cellular processes and is aberrantly activated in cancers, contributing to the occurrence an...
Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt
A signaling pathway was delineated by which insulin-like growth factor 1 (IGF-1) promotes the survival of cerebellar neurons. IGF-1 activation of phosphoinositide 3-kinase (PI3-...
The coordinate regulation of the p53 and mTOR pathways in cells
Cell growth and proliferation requires an intricate coordination between the stimulatory signals arising from nutrients and growth factors and the inhibitory signals arising fro...
mTOR at the nexus of nutrition, growth, ageing and disease
The mTOR pathway integrates a diverse set of environmental cues, such as growth factor signals and nutritional status, to direct eukaryotic cell growth. Over the past two and a ...
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling is one of the most important intracellular pathways, which can be considered as a master ...
Publication Info
- Year
- 2019
- Type
- review
- Volume
- 59
- Pages
- 125-132
- Citations
- 1089
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1089
OpenAlex
Cite This
Ali S. Alzahrani
(2019).
PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside.
Seminars in Cancer Biology
, 59
, 125-132.
https://doi.org/10.1016/j.semcancer.2019.07.009
Identifiers
- DOI
- 10.1016/j.semcancer.2019.07.009